| Schedule of Net Loss Per Common Share of Basic and Diluted |
|
|
|
Three months ended
December 31,
|
| |
|
2023
|
|
2022
|
| |
|
Class A
|
|
Class B
|
|
Common
Stock
|
|
Basic net income (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Numerator:
|
|
|
|
|
|
|
|
|
|
|
|
|
Allocation of net income (loss)
|
|
$
|
834 |
|
$
|
101 |
|
|
$
|
(9,390 |
)
|
|
Denominator:
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average shares outstanding
|
|
|
18,617,656 |
|
|
2,254,901 |
|
|
|
12,379,480 |
|
|
Basic net income (loss) per share
|
|
$
|
0.04 |
|
$
|
0.04 |
|
|
$
|
(0.76 |
)
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
Diluted net income (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Numerator:
|
|
|
|
|
|
|
|
|
|
|
|
|
Allocation of net income (loss)
|
|
$
|
834 |
|
$
|
101 |
|
|
$
|
(9,390 |
)
|
|
Reallocation of net income as a result of conversion of Class B to Class A Common Stock
|
|
|
101 |
|
|
—
|
|
|
|
—
|
|
|
Reallocation of net income
|
|
|
—
|
|
|
(11 |
)
|
|
|
—
|
|
|
Allocation of net income (loss)
|
|
|
935 |
|
|
90 |
|
|
|
(9,390 |
)
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
Denominator:
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares used in basic earnings per share calculation
|
|
|
18,617,656 |
|
|
2,254,901 |
|
|
|
12,379,480 |
|
|
Conversion of Class B to Class A Common Stock
|
|
|
2,254,901 |
|
|
—
|
|
|
|
—
|
|
|
Dilutive effect of stock options, warrants and RSUs
|
|
|
2,443,514 |
|
|
—
|
|
|
|
—
|
|
|
Number of shares used in per share computation
|
|
|
23,316,071 |
|
|
2,254,901 |
|
|
|
12,379,480 |
|
|
Diluted net income (loss) per share
|
|
$
|
0.04 |
|
$
|
0.04 |
|
|
$
|
(0.76 |
)
|
|
|
|
|
Year ended September 30,
|
| |
|
2023
|
|
2022
|
|
Numerator:
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(39,621 |
)
|
|
$
|
(23,867 |
)
|
| |
|
|
|
|
|
|
|
|
| Denominator: |
|
|
|
|
|
|
|
|
| Weighted-average common shares outstanding – basic and diluted |
|
|
14,612,600 |
|
|
|
10,620,614 |
|
| |
|
|
|
|
|
|
|
|
| Net loss per common share – basic and diluted |
|
$ |
(2.71 |
) |
|
$ |
(2.25 |
) |
|
| Schedule of Dilutive Securities Not Included in Net Loss Per Common Share |
The potential shares of Class A Common Stock that were excluded from the computation of diluted net income (loss) per share attributable to stockholders for the periods presented because including them would have an antidilutive effect were as follows:
|
|
|
Three months ended
December 31,
|
| |
|
2023
|
|
2022
|
|
Public Warrants and Private Warrants
|
|
9,000,000 |
|
—
|
|
Make-whole shares
|
|
1,052,030 |
|
—
|
|
Earnout shares
|
|
3,500,000 |
|
—
|
|
RSUs
|
|
—
|
|
10,984,241 |
|
Stock options
|
|
1,690,476 |
|
6,400,758 |
|
Convertible preferred stock (on an as-converted basis)
|
|
—
|
|
2,254,901 |
|
Common stock warrants
|
|
—
|
|
400,000 |
|
Convertible notes
|
|
—
|
|
131,072 |
| |
|
15,242,506 |
|
20,170,972 |
|
The following table shows potentially dilutive securities not included in the computation of the Company’s net loss per common share:
|
|
|
Year ended September 30,
|
| |
|
2023
|
|
2022
|
|
Restricted stock units
|
|
209,494 |
|
10,984,241 |
|
Stock options
|
|
5,905,684 |
|
5,754,052 |
|
Convertible preferred stock (on an as-converted basis)
|
|
2,254,901 |
|
2,254,901 |
|
Common stock warrants
|
|
700,388 |
|
200,000 |
|
Convertible notes
|
|
—
|
|
129,482 |
| |
|
9,070,467 |
|
19,322,676 |
|